Anmodning om ophævelse af suspension af afdelinger i Investeringsforeningen Nordea Invest
De tekniske problemer er nu løst og det er igen muligt at stille priser for nedenstående afdelinger, hvorfor handelen med nedenstående afdelinger genoptages.
| Short name | Navn | ISIN |
| NDINSCKL1 | Nordea Invest Nordic Small Cap KL 1 | DK0015974695 |
| NDIESCSKL1 | Nordea Invest European Small Cap Stars KL 1 | DK0015960983 |
| NDIDKKL1 | Nordea Invest Danmark KL 1 | DK0010265859 |
| NDIGSCKL1 | Nordea Invest Global Small Cap KL 1 | DK0016050974 |
| NDIEUSTKL1 | Nordea Invest European Stars KL 1 | DK0010265693 |
| NDINASTKL1 | Nordea Invest North American Stars KL 1 | DK0010265776 |
| NDIGUAKL1 | Nordea Invest Globale UdbytteAktier KL 1 | DK0010265503 |
| NDIGOBLKL1 | Nordea Invest Globale obligationer KL 1 | DK0010170398 |
| NDIMLOKL1 | Nordea Invest Mellemlange obligationer KL 1 | DK0015168686 |
| NDIAKTIIKL1 | Nordea Invest Aktier II KL 1 | DK0015357065 |
| NDIEHYKL1 | Nordea Invest European HYB KL 1 | DK0016306798 |
| NDIDAFKL1 | Nordea Invest Danske aktier fokus KL 1 | DK0060012466 |
| NDIAKL1 | Nordea Invest Aktier KL 1 | DK0010250158 |
| NDIVOBKL1 | Nordea Invest Virksomhedsobligationer KL 1 | DK0016015399 |
| NDIVOHKL1 | Nordea Invest Virksomhedsobli. Højrente KL1 | DK0016067432 |
| NDIHOJLKL1 | Nordea Invest HøjrenteLande KL 1 | DK0016254899 |
| NDIGSTKL1 | Nordea Invest Global Stars KL 1 | DK0010301324 |
| NDIEMKL1 | Nordea Invest Emerging Markets KL 1 | DK0010308170 |
| NDIKOLKL1 | Nordea Invest Korte obligationer Lagerbeskattet KL 1 | DK0060014678 |
| NDISTABKL1 | Nordea Invest Stabil Balanceret KL 1 | DK0060014595 |
| NDISTABAKL1 | Nordea Invest Stabile Aktier KL 1 | DK0060048304 |
| NDINOSKL1 | Nordea Invest Nordic Stars KL 1 | DK0060095735 |
| NDISTAAKL1 | Nordea Invest Stabile Aktier Akkumulerende KL 1 | DK0060096030 |
| NDI4KL1 | Nordea Invest Basis 4 KL 1 | DK0060075893 |
| NDIB1KL1 | Nordea Invest Basis 1 KL 1 | DK0016195860 |
| NDIB2KL1 | Nordea Invest Basis 2 KL 1 | DK0016195944 |
| NDIB3KL1 | Nordea Invest Basis 3 KL 1 | DK0016196082 |
| NDIKMKL1 | Nordea Invest Klima og Miljø KL 1 | DK0060192185 |
| NDIGAIKL1 | Nordea Invest Globale Aktier Indeks KL 1 | DK0060451623 |
| NDIESKL1 | Nordea Invest Emerging Stars KL 1 | DK0060586394 |
| NDINAEKL1 | Nordea Invest North America Enhanced KL 1 | DK0060831451 |
| NDIGLENHKL1 | Nordea Invest Global Enhanced KL 1 | DK0060949881 |
| NDIEUENHKL1 | Nordea Invest Europe Enhanced KL 1 | DK0060949964 |
| NDIJAPENHKL1 | Nordea Invest Japan Enhanced KL 1 | DK0060950038 |
| NDIEMMAENKL1 | Nordea Invest Emerging Markets Enhanced KL 1 | DK0060950111 |
| NDIGSEKL1 | Nordea Invest Global Small Cap Enhanced KL 1 | DK0061112893 |
| NDIBAKL1 | Nordea Invest Bæredygtige Aktier KL 1 | DK0061116027 |
| NDIBOKL1 | Nordea Invest Bæredygtige Obligationer KL 1 | DK0061139748 |
| NDIFONKL1 | Nordea Invest Fonde KL 1 | DK0060145183 |
| NDIKOKL1 | Nordea Invest Korte obligationer KL 1 | DK0060268506 |
| NDIVOMKL1 | Nordea Invest Verdens Obligationsmarkeder KL 1 | DK0060353886 |
| NDILAOKL1 | Nordea Invest Lange Obligationer KL 1 | DK0060187342 |
Med venlig hilsen
Nordea Invest
Tom Holflod
Senior Product Manager
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Sai Life Sciences reaffirms commitment to Sustainability, charts out SDGs to be achieved by FY276.6.2023 12:41:52 CEST | Press release
HYDERABAD, India, June 06, 2023 (GLOBE NEWSWIRE) -- On the World Environment Day 2023, Sai Life Sciences, a global Contract Research, Development & Manufacturing Organization (CRO-CDMO), announced its renewed Sustainable Development Goals (SDG) charting out the roadmap to achieve specific environmental, social and governance (ESG) targets by the financial year ending March 31, 2027. Making the announcement, Krishna Kanumuri, CEO & Managing Director, Sai Life Sciences, said, “Our renewed Sustainable Development Goals reflect a coming of age of our Sustainability journey. The learnings and successes from the first edition have shaped our aspiration for this phase and signify a certain boldness that comes with persevering unabated on a chosen path. While Sustainability has always been at the heart of our ethos at Sai Life Sciences, I must thank all our customers and partners for inspiring us raise the bar each day.” Sai Life Sciences first charted out its SDGs in 2019 with a three-year ti
Calibre Announces the Publication of its 2022 Sustainability Report, Demonstrating Commitment to Transparency and Responsible Practices6.6.2023 12:00:55 CEST | Press release
VANCOUVER, British Columbia, June 06, 2023 (GLOBE NEWSWIRE) -- Calibre Mining Corp. (TSX: CXB; OTCQX: CXBMF) (“Calibre” or the “Company”) is pleased to announce the publication of its 2022 Sustainability Report (“the Report”). The Report outlines Calibre’s 2022 progress and achievements, provides guidance for the Company’s Environmental, Social and Governance (“ESG”) performance, and underscores Calibre’s unwavering commitment to transparency, accountability and responsible business practices. Calibre acknowledges that incorporating sustainability into its business strategy is essential to our long-term success. In 2022, the Company saw record production for the third consecutive year. Calibre’s increasing focus on sustainability practices and robust ESG performance ensures that such accomplishments are achieved in ways that are ethical, transparent, accountable, and respectful of the rights of others. Darren Hall, President and Chief Executive Officer, stated: “At Calibre, we recogniz
Noted Vaccine Researcher Thomas P. Monath Awarded Sabin’s Gold Medal; Cameroon Physician Sangwe Clovis Nchinjoh Receives Rising Star Award6.6.2023 12:00:00 CEST | Press release
WASHINGTON, June 06, 2023 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute today awarded the 30th Albert B. Sabin Gold Medal Award to Thomas P. Monath, MD, and its Rising Star Award to Sangwe Clovis Nchinjoh, MD, MPH, in a ceremony at Washington D.C.’s National Academy of Sciences building. Dr. Monath was selected for the Gold Medal for his more than four decades of commitment to advancing knowledge of arboviruses and vaccine research and development (R&D) that contributed to the development of several innovative vaccines including those for Ebola Zaire, smallpox, dengue, Japanese encephalitis and West Nile. The Gold Medal, celebrating three decades of recognition, is Sabin’s highest scientific honor. It is given annually to a distinguished member of the global health community who has made exceptional contributions to vaccinology or a complementary field. Past award recipients include leaders of vaccinology and vaccine advocacy such as Drs. Barney Graham, Carol Baker, Bill Foege, Anne
PRESS RELEASE: SSH launches OpenSSH support service for multi-platform SSH environments6.6.2023 12:00:00 CEST | Press release
Helsinki, Finland - June 6, 2023 - To resolve various customer support problems regarding OpenSSH implementations, SSH has launched a support service for OpenSSH. As a result, customers benefit from high-quality SSH support services also for the open-source variant of SSH software. OpenSSH will be supported on Windows and Red Hat Linux platforms. The SSH protocol is a secure network protocol used to establish encrypted and secure remote connections and transfer data between different systems. OpenSSH is an open-source implementation of the SSH protocol. It was initially released as a free version of SSH’s Tectia product. As an open-source product, OpenSSH is popular, especially as SSH client software. However, its usage in critical corporate environments has been partly limited due to a lack of high-quality support services or support from a single source for all SSH clients. Without proper support services, customers often invest in in-house OpenSSH expertise, resulting in increased o
Novo Nordisk A/S – Share repurchase programme6.6.2023 11:56:26 CEST | Press release
Bagsværd, Denmark, 6June 2023 – On 9 May 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 30 billion to be executed during a 12-month period beginning 1 February 2023. Under the programme initiated 9 May 2023, Novo Nordisk will repurchase B shares for an amount up to DKK 5.8 billion in the period from 10 May 2023 to 8 August 2023. Since the announcement 30 May of the programme, the following transactions have been made: Number of B sharesAverage purchase priceTransaction value, DKKAccumulated, last announcement906,0001,042,810,01330 May 202382,7001,123.3192,897,99931 May 202385,0001,117.9295,023,0001 June 202385,0001,109.7994,332,2702 June 202390,0001,076.5596,889,206Accumulated under the